Piramal Pharma Limited (NSE:PPLPHARMA)
India flag India · Delayed Price · Currency is INR
225.54
+0.01 (0.00%)
Apr 2, 2025, 9:30 AM IST

Piramal Pharma Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '25 Mar '24 Mar '23 Mar '22 Mar '21
Market Capitalization
298,996170,52881,683--
Market Cap Growth
92.16%108.77%---
Enterprise Value
342,776209,922130,128--
Last Close Price
225.53128.8166.80--
PE Ratio
768.63956.95---
Forward PE
70.7942.3340.39--
PS Ratio
3.352.091.15--
PB Ratio
3.792.151.21--
P/TBV Ratio
9.464.713.51--
P/FCF Ratio
58.30---
P/OCF Ratio
16.9816.88--
PEG Ratio
0.941.581.35--
EV/Sales Ratio
3.832.571.84--
EV/EBITDA Ratio
23.2018.4322.58--
EV/EBIT Ratio
47.7945.62---
EV/FCF Ratio
71.77---
Debt / Equity Ratio
0.610.600.830.620.54
Debt / EBITDA Ratio
3.404.009.213.632.30
Debt / FCF Ratio
-16.10---
Asset Turnover
-0.550.520.57-
Inventory Turnover
-1.691.941.87-
Quick Ratio
-0.610.640.690.82
Current Ratio
-1.251.261.341.47
Return on Equity (ROE)
-0.24%-2.77%6.11%-
Return on Assets (ROA)
-1.93%-0.20%2.96%-
Return on Capital (ROIC)
3.24%2.30%-0.24%3.60%-
Return on Capital Employed (ROCE)
-4.20%-5.70%10.50%
Earnings Yield
0.13%0.10%-2.28%--
FCF Yield
1.71%-5.89%--
Dividend Yield
0.05%0.08%---
Payout Ratio
0.00%--13.30%-
Buyback Yield / Dilution
-8.30%-7.85%-0.95%-87.83%-
Total Shareholder Return
-8.25%-7.76%-0.95%-87.83%-
Updated Jan 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.